Trxade Group Inc (MEDS) - Total Assets
Based on the latest financial reports, Trxade Group Inc (MEDS) holds total assets worth $14.85 Million USD as of June 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore MEDS working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Trxade Group Inc - Total Assets Trend (2006–2023)
This chart illustrates how Trxade Group Inc's total assets have evolved over time, based on quarterly financial data.
Trxade Group Inc - Asset Composition Analysis
Current Asset Composition (December 2023)
Trxade Group Inc's total assets of $14.85 Million consist of 22.0% current assets and 78.0% non-current assets. Also see Trxade Group Inc market capitalisation for the company's overall valuation and market capitalisation.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 1.2% |
| Accounts Receivable | $2.49 Million | 19.9% |
| Inventory | $968.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $8.96 Million | 71.5% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2006–2023)
This chart illustrates how Trxade Group Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See MEDS share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Trxade Group Inc's current assets represent 22.0% of total assets in 2023, a decrease from 100.0% in 2006.
- Cash Position: Cash and equivalents constituted 1.2% of total assets in 2023, down from 100.0% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 71.0% of total assets, an increase from 0.0% in 2006.
- Asset Diversification: The largest asset category is intangible assets at 71.5% of total assets.
Trxade Group Inc Competitors by Total Assets
Key competitors of Trxade Group Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.69 Billion |
|
Redcare Pharmacy NV
F:RDC
|
Germany | €1.21 Billion |
|
Redcare Pharmacy NV
XETRA:RDC
|
Germany | €1.18 Billion |
|
Empreendimentos Pague Menos S.A
SA:PGMN3
|
Brazil | R$9.81 Billion |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3
|
Brazil | R$1.95 Billion |
|
High Tide Inc
V:HITI
|
Canada | CA$347.87 Million |
|
Raia Drogasil S.A
SA:RADL3
|
Brazil | R$25.13 Billion |
|
Yifeng Pharmacy
SHG:603939
|
China | CN¥26.07 Billion |
Trxade Group Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.16 | 0.49 | 4.51 |
| Quick Ratio | 4.16 | 0.45 | 4.45 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $9.17 Million | $-2.17 Million | $3.36 Million |
Trxade Group Inc - Advanced Valuation Insights
This section examines the relationship between Trxade Group Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.76 |
| Latest Market Cap to Assets Ratio | 0.19 |
| Asset Growth Rate (YoY) | 237.8% |
| Total Assets | $12.53 Million |
| Market Capitalization | $2.40 Million USD |
Valuation Analysis
Below Book Valuation: The market values Trxade Group Inc's assets below their book value (0.19x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Trxade Group Inc's assets grew by 237.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Trxade Group Inc (2006–2023)
The table below shows the annual total assets of Trxade Group Inc from 2006 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $12.53 Million | +237.81% |
| 2022-12-31 | $3.71 Million | -35.66% |
| 2021-12-31 | $5.77 Million | -41.12% |
| 2020-12-31 | $9.79 Million | +75.76% |
| 2019-12-31 | $5.57 Million | +150.11% |
| 2018-12-31 | $2.23 Million | +260.76% |
| 2017-12-31 | $617.48K | +83.16% |
| 2016-12-31 | $337.12K | -83.37% |
| 2015-12-31 | $2.03 Million | +65.91% |
| 2014-12-31 | $1.22 Million | +202.60% |
| 2013-12-31 | $403.87K | +240.31% |
| 2012-12-31 | $118.68K | -82.73% |
| 2008-12-31 | $687.00K | +38691.64% |
| 2007-12-31 | $1.77K | -86.56% |
| 2006-12-31 | $13.17K | -- |
About Trxade Group Inc
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.